TY - JOUR
T1 - ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
AU - Colombo, Nicoletta
AU - Creutzberg, Carien
AU - Amant, Frederic
AU - Bosse, Tjalling
AU - González-Martín, Antonio
AU - Ledermann, Jonathan
AU - Marth, Christian
AU - Nout, Remi
AU - Querleu, Denis
AU - Mirza, Mansoor Raza
AU - Sessa, Cristiana
AU - AUTHOR GROUP
AU - Abal, Miguel
AU - Altundag, Ozden
AU - Banerjee, Susana
AU - Casado, Antonio
AU - Chiva de Agustín, Luis
AU - Cibula, David
AU - del Campo, Josep-María
AU - Emons, Günter
AU - Goffin, Frédéric
AU - Greggi, Stefano
AU - Haie-Meder, Christine
AU - Katsaros, Dionyssios
AU - Kesic, Vesna
AU - Kurzeder, Christian
AU - Lax, Sigurd
AU - Lécuru, Fabrice
AU - Levy, Tally
AU - Lorusso, Domenica
AU - Mäenpää, Johanna
AU - Matias-Guiu, Xavier
AU - Morice, Philippe
AU - Nijman, Hans W.
AU - Powell, Melanie
AU - Mirza, Mansoor R.
AU - Reed, Nick
AU - Rodolakis, Alexandros
AU - Salvesen, Helga
AU - Sehouli, Jalid
AU - Taylor, Alexandra
AU - Westermann, Anneke
AU - Zeimet, Alain G.
PY - 2015
Y1 - 2015
N2 - The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy 82 Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article. (C) 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
AB - The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy 82 Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article. (C) 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
U2 - https://doi.org/10.1016/j.radonc.2015.11.013
DO - https://doi.org/10.1016/j.radonc.2015.11.013
M3 - Article
C2 - 26683800
SN - 0167-8140
VL - 117
SP - 559
EP - 581
JO - Radiotherapy and oncology
JF - Radiotherapy and oncology
IS - 3
ER -